Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 17 min ago
PreprintarXiv licencearXiv

BRIDGE: An Acceptance Gate to Block False Improvements in Model Updates, with a Retrospective Clinical Evaluation

Abstract

Models are updated repeatedly, and an update that looks better on validation data but not on new data is a false improvement that can misguide clinical decisions. The naive rule accepts every positive validation gain and is optimistic when the same data choose and judge the update. BRIDGE is a model-agnostic acceptance gate that decides each update from predictions and the available labels, with fixed settings. Each fold of the data judges the update chosen on the other folds (cross-fitting) to reduce selection bias; acceptance requires the gain's lower bootstrap bound to exceed a margin. The four settings are (A) 11 new datasets, (B) synthetic tasks, (C) 12 retrospective clinical tasks, and (D) 39 supporting datasets. The false-improvement rate falls from 19.1% (naive) to 1.1% (BRIDGE) in (A), 20.7% to 1.7% (B), 20.0% to 0% (C), and 12.5% to 0.5% (D); every 95% confidence interval of the reduction over datasets or tasks excludes zero (not over the clinical sources). An equal-size random draw from the naive acceptances contains more false improvements in (A)-(E) (post hoc, p<0.001). On the OpenML collection (E) of 14 new datasets, the false-improvement rate falls from 25.6% to 1.0%. BRIDGE removes 97% to 100% of the false improvements that the naive rule accepts, and its mean gain per deployed update is 1.8 to 3.1 times the naive rule's. The 95% upper bound on the false-improvement rate is below 5.5%: formal in (B) for independent tasks (3.56%), and conditional on the real data tested (0.33% to 5.40%).

Related

  1. Spectral Improvements of Geometric Inequalities on Closed Kähler Manifolds
    Sayantan Chakraborty, Xiaodong Wang, Tian Wu
    arXivPreprintarXiv licenceFull textAnalysis & PDEsGeometry & topologyarXiv
  2. Almost-orthogonal Strichartz estimates and radial improvements
    Hongzhou Ji, Liping Xu, An Zhang
    arXivPreprintarXiv licenceFull textAnalysis & PDEsarXiv
  3. Distribution-Dependent Improvements of McDiarmid's Inequality via Rényi Divergence
    Amedeo Roberto Esposito, Adrien Vandenbroucque, Michael Gastpar
    arXivPreprintCC BY 4.0Full textProbabilityarXiv
  4. Improvements of Classical Eigenvalue Inequalities I: Quantitative Hersch-deficit and the Joint Spectral Range on the Two-Sphere
    Zuoqin Wang, Qingwei Zeng
    arXivPreprintarXiv licenceFull textAnalysis & PDEsarXiv
  5. Optimal Non-Homogeneous Improvements of the Anisotropic Hardy Inequality
    Giuseppina di Blasio, Giovanni Pisante, Georgios Psaradakis
    arXivPreprintarXiv licenceFull textAnalysis & PDEsarXiv
BibTeX
@misc{sunaryono2026bridge,
  title = {{BRIDGE: An Acceptance Gate to Block False Improvements in Model Updates, with a Retrospective Clinical Evaluation}},
  author = {Dwi Sunaryono},
  howpublished = {arXiv},
  year = {2026},
  month = oct,
  doi = {10.48550/arxiv.2610.29515},
  eprint = {2610.29515},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2610.29515},
}
RIS
TY  - UNPB
TI  - BRIDGE: An Acceptance Gate to Block False Improvements in Model Updates, with a Retrospective Clinical Evaluation
AU  - Dwi Sunaryono
PY  - 2026
DA  - 2026/10/27
PB  - arXiv
DO  - 10.48550/arxiv.2610.29515
UR  - https://arxiv.org/abs/2610.29515
AB  - Models are updated repeatedly, and an update that looks better on validation data but not on new data is a false improvement that can misguide clinical decisions. The naive rule accepts every positive validation gain and is optimistic when the same data choose and judge the update. BRIDGE is a model-agnostic acceptance gate that decides each update from predictions and the available labels, with fixed settings. Each fold of the data judges the update chosen on the other folds (cross-fitting) to reduce selection bias; acceptance requires the gain's lower bootstrap bound to exceed a margin. The four settings are (A) 11 new datasets, (B) synthetic tasks, (C) 12 retrospective clinical tasks, and (D) 39 supporting datasets. The false-improvement rate falls from 19.1% (naive) to 1.1% (BRIDGE) in (A), 20.7% to 1.7% (B), 20.0% to 0% (C), and 12.5% to 0.5% (D); every 95% confidence interval of the reduction over datasets or tasks excludes zero (not over the clinical sources). An equal-size random draw from the naive acceptances contains more false improvements in (A)-(E) (post hoc, p<0.001). On the OpenML collection (E) of 14 new datasets, the false-improvement rate falls from 25.6% to 1.0%. BRIDGE removes 97% to 100% of the false improvements that the naive rule accepts, and its mean gain per deployed update is 1.8 to 3.1 times the naive rule's. The 95% upper bound on the false-improvement rate is below 5.5%: formal in (B) for independent tasks (3.56%), and conditional on the real data tested (0.33% to 5.40%).
ER  -